Oncocyte (OCX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Jun17

OncoCyte Corporation renamed to iMDx and moved headquarters

11:34

May19

Oncocyte’s Next-Generation LDT Receives Favorable Pricing Update

20:22

May13

Oncocyte Corporation Reports Strong Q1 2025 Earnings

10:24

May12

Oncocyte released FY2025 Q1 earnings on May 12 After-Market EST, actual revenue USD 2.138 M (forecast USD 126.78 K), actual EPS USD -0.2596 (forecast USD -0.2375)

23:00

OncoCyte Reports Q1 2025 Earnings: Revenue Beats, Loss Widens

20:12

May10

OncoCyte Corp Expected To Report Loss Of 24 Cents Per Share

00:38

Schedules & Filings

Schedules

Filings

Jun18

Ticker Change(EST)

From 06.18 changed to IMDX

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.138 M, Net Income -6.671 M, EPS -0.2596

Mar24

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 1.486 M, Net Income -33.51 M, EPS -1.9279

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change